On June 14, 2024, Anthony Hunt, CEO of Repligen Corp (NASDAQ:RGEN), purchased 2,000 shares of the company, as reported in a recent SEC Filing.
On June 14, 2024, Nicolas Barthelemy, a director at Repligen Corp (NASDAQ:RGEN), purchased 1,200 shares of the company, as reported in a recent SEC Filing.
Repligen (RGEN) appoints Olivier Loeillot as the company's new president and chief executive officer, effective from Sep 1, 2024. Stock falls on the news.